Novartis Sells Landmark Grimsby API Plant to Site Developer IPP

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Novartis International AG (NYSE:NVS) (Basel, Switzerland) is selling its Grimsby active pharmaceutical ingredients (API) plant in the U.K. to a subsidiary of International Process Plants (IPP) (New Jersey). IPP supplies used process plants and secondhand process equipment.

Subscribers can click here for a project report on the related plant closure, and click here for a plant profile.

The plant has been in operation since 1951.

Novartis will continue operations at the site through December 2022, with the IPP subsidiary taking over the site in 2023. Industrial Info first reported Novartis' intent to close and sell the plant in 2018.

Sited on 170 acres, the plant has grown to more than 500,000 square feet. It includes 90 reaction suites, 17 centrifuges, 26 dryer systems, three milling systems, 10 solvent recovery systems, modern labs and offices, and a wastewater treatment facility. The plant is capable of manufacturing multiple APIs.

Industrial Info Resources (IIR) is the world's leading provider of market intelligence across the upstream, midstream and downstream energy markets and all other major industrial markets. IIR's Global Market Intelligence Platform (GMI) supports our end-users across their core businesses, and helps them connect trends across multiple markets with access to real, qualified and validated project opportunities. Follow IIR on: LinkedIn.